Neurotauincis A Biotech Companyformed In 2017That Focuses On Developing Drugs That Target The Disruption Or Decay Of The Important Neurobiological Protein Called Tauand Other Important And Associated Proteins Like Amyloid And Processes To Reduce Harmful Inflammation That Can Lead To Many Serious Diseases With Significant Unmet Medical Needs Our Development Programs Are Primarily Focused On Neurodegenerative & Neuromuscular Diseases Includingprogressive Supranuclear Palsyfrontotemporal Dementiaalzheimer S Diseasetraumatic Brain Injuryptsddown S Syndromeand Parkinson Disease On Going Research Has Linked These Diseases To Various Malfunctions Of Tauamyloid And Inflammation Within The Brainby Correcting Themneurotau Aims At Opening The Way For A Broad Range Of Disease Modifying Mechanism Based Therapies Neurotau Is Led By A Team Of Scientificclinical And Industry Executives With Over 75 Years Of Combined Experience And A Passion To Bring Forward Breakthrough Drug Therapies For A Host Of Brain Related Diseases
No conferences found for this company.
| Company Name | Neurotau Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
